D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Emerson Electric
EMR
|
+$546M |
| 2 |
Amazon
AMZN
|
+$515M |
| 3 |
Tesla
TSLA
|
+$389M |
| 4 |
Netflix
NFLX
|
+$322M |
| 5 |
Adobe
ADBE
|
+$305M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$836M |
| 2 |
CELG
Celgene Corp
CELG
|
+$460M |
| 3 |
NVIDIA
NVDA
|
+$429M |
| 4 |
ConocoPhillips
COP
|
+$311M |
| 5 |
Biogen
BIIB
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.23% |
| 2 | Consumer Discretionary | 11.75% |
| 3 | Healthcare | 9.92% |
| 4 | Financials | 7.86% |
| 5 | Industrials | 6.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
CALL
Extra Space Storage
EXR
$32.7B
| $1.82M | ﹤0.01% |
17,200
| – | – |
|
2502
Archrock
AROC
$6.23B
| $1.81M | ﹤0.01% |
180,543
-10,944
| -6% | -$102K |
|
2503
Evolution Petroleum
EPM
$132M
| $1.81M | ﹤0.01% |
331,371
+15,772
| +5% | +$86.8K |
|
2504
CALL
RTX Corp
RTX
$296B
| $1.81M | ﹤0.01% |
19,227
-28,443
| -60% | -$2.58M |
|
2505
Enpro
NPO
$6.41B
| $1.81M | ﹤0.01% |
27,069
-14,116
| -34% | -$938K |
|
2506
Helix Energy Solutions
HLX
$1.36B
| $1.81M | ﹤0.01% |
187,731
-77,894
| -29% | -$674K |
|
|
CGC
2507
Canopy Growth
CGC
$373M
| $1.81M | ﹤0.01% |
8,569
+3,249
| +61% | +$645K |
|
|
AXON
2508
PUT
Axon Enterprise
AXON
$44.5B
| $1.8M | ﹤0.01% |
24,600
| – | – |
|
2509
Bristow Group
VTOL
$1.34B
| $1.8M | ﹤0.01% |
88,612
+704
| +0.8% | +$13.9K |
|
|
PRO
2510
CALL
DELISTED
PROS Holdings
PRO
| $1.8M | ﹤0.01% |
30,000
| – | – |
|
2511
CALL
Trex
TREX
$4.47B
| $1.8M | ﹤0.01% |
+40,000
| New | +$1.76M |
|
2512
Northwest Bancshares
NWBI
$2.33B
| $1.8M | ﹤0.01% |
108,071
+35,465
| +49% | +$593K |
|
2513
PUT
Affiliated Managers Group
AMG
$9.76B
| $1.8M | ﹤0.01% |
21,200
-22,800
| -52% | -$1.87M |
|
2514
Malibu Boats
MBUU
$554M
| $1.8M | ﹤0.01% |
43,865
-3,094
| -7% | -$112K |
|
|
HUYA
2515
PUT
Huya Inc
HUYA
$565M
| $1.79M | ﹤0.01% |
+100,000
| New | +$2.11M |
|
2516
MediciNova
MNOV
$63.5M
| $1.79M | ﹤0.01% |
266,863
-135,515
| -34% | -$1.02M |
|
2517
Prestige Consumer Healthcare
PBH
$2.46B
| $1.79M | ﹤0.01% |
44,265
-77,508
| -64% | -$2.89M |
|
2518
Scholastic
SCHL
$780M
| $1.79M | ﹤0.01% |
46,604
+5,922
| +15% | +$223K |
|
|
ESPR
2519
PUT
DELISTED
Esperion Therapeutics
ESPR
| $1.79M | ﹤0.01% |
30,000
-50,000
| -63% | -$2.25M |
|
2520
BrightView Holdings
BV
$1.25B
| $1.78M | ﹤0.01% |
105,773
+20,541
| +24% | +$357K |
|
2521
PUT
Old Dominion Freight Line
ODFL
$45.8B
| $1.78M | ﹤0.01% |
+28,200
| New | +$1.73M |
|
2522
Andersons Inc
ANDE
$2.44B
| $1.78M | ﹤0.01% |
70,455
+23,840
| +51% | +$521K |
|
2523
PUT
Elastic
ESTC
$6.84B
| $1.78M | ﹤0.01% |
+27,700
| New | +$2.03M |
|
|
ANAT
2524
DELISTED
American National Group, Inc. Common Stock
ANAT
| $1.78M | ﹤0.01% |
15,107
-795
| -5% | -$94.1K |
|
2525
Vanda Pharmaceuticals
VNDA
$302M
| $1.77M | ﹤0.01% |
107,893
-181,070
| -63% | -$2.74M |
|
Similar funds
D.E. Shaw & Co's Q4 2019 Portfolio in Review
As of Q4 2019, D.E. Shaw & Co held 4,337 positions worth $87.5B, up 7.7% from $81.2B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
D.E. Shaw & Co's Q4 2019 filing shows 572 new, 1,477 increased, 1,498 reduced and 412 closed positions. Its largest new stake was Tesla: 17,953,230 shares worth $501M. The largest sale was Alibaba, an estimated $836M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- D.E. Shaw & Co's largest Q4 2019 buy was Tesla: 17,953,230 shares worth $501M.
- D.E. Shaw & Co added most to Emerson Electric in Q4 2019, an estimated $546M increase.
- D.E. Shaw & Co's biggest Q4 2019 reduction was Alibaba, cutting an estimated $836M.
- D.E. Shaw & Co fully exited Celgene Corp in Q4 2019, selling an estimated $460M.
- D.E. Shaw & Co's ten largest holdings make up 10% of its $87.5B portfolio in Q4 2019.
- D.E. Shaw & Co opened 572 new positions and closed 412 in Q4 2019.
- D.E. Shaw & Co's portfolio value rose 7.7% quarter-over-quarter to $87.5B.
Based on D.E. Shaw & Co's 13F filing for Q4 2019, filed 14 Feb 2020.